hema.to
PrivateLast Round
Seed
Feb 27, 2025
Total Funding Raised
$7.71M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
hema.to operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Seed round in February 2025.
hema.to is a medtech company that provides a cloud-based software-as-a-service (SaaS) platform using artificial intelligence to automate the analysis of blood data for diagnostic support.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, Precision Medicine, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
hema.to Comparables
Compare hema.to with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AHEAD Medicine | 90% | |
| FlowView Diagnostics BV | 85% | |
| METAFORA Biosystems | 82% |
For institutional investors. Book with your work email.
hema.to Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 27, 2025 | ||||
| Seed | Jun 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
hema.to Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LUMO Labs | Seed |
| Elaia Partners | Seed |
| Bayern Kapital | Seed |
| High-Tech Gründerfonds | Seed |
| Cross Atlantic Angels | Seed |
| Heal Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 312% MoM.
- Nov 14, 2025
Collaborating with HpH Institut and Pathodiagnostik Berlin on AI cytometry.
For institutional investors. Book with your work email.
hema.to Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about hema.to's valuation, stock price, and market status.
Is hema.to a public or private company?
hema.to is a private company.
What is the current stock price of hema.to?
hema.to is a private company, so its shares have no public market price. Caplight tracks hema.to's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is hema.to worth (valuation)?
Valuation information for hema.to is not publicly available.
Can I buy hema.to stock?
hema.to shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was hema.to's last funding round?
hema.to's most recent funding round was Seed on February 27, 2025.
Who are the main investors in hema.to?
Key investors in hema.to include LUMO Labs, Elaia Partners, Heal Capital.
Will hema.to IPO soon?
No public IPO plans have been announced for hema.to.
How can I track hema.to secondary market activity?
Caplight tracks bids, offers, and trades in hema.to's shares on secondary markets.